| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |